ATE132039T1 - Verwendung von steroidderivaten zur behandlung der endometriose - Google Patents
Verwendung von steroidderivaten zur behandlung der endometrioseInfo
- Publication number
- ATE132039T1 ATE132039T1 AT91105883T AT91105883T ATE132039T1 AT E132039 T1 ATE132039 T1 AT E132039T1 AT 91105883 T AT91105883 T AT 91105883T AT 91105883 T AT91105883 T AT 91105883T AT E132039 T1 ATE132039 T1 AT E132039T1
- Authority
- AT
- Austria
- Prior art keywords
- treat endometriosis
- steroid derivatives
- endometriosis
- treat
- androstene
- Prior art date
Links
- 201000009273 Endometriosis Diseases 0.000 title abstract 3
- 150000003431 steroids Chemical class 0.000 title 1
- UKVVNEHFNYKGMX-KIVPVIKRSA-N (8r,9s,10r,13s,14r)-14-hydroxy-10,13-dimethyl-2,7,8,9,11,12,15,16-octahydro-1h-cyclopenta[a]phenanthrene-3,6,17-trione Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@]4(O)[C@@H]3CC(=O)C2=C1 UKVVNEHFNYKGMX-KIVPVIKRSA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2097379A JP2602456B2 (ja) | 1990-04-12 | 1990-04-12 | 子宮内膜症治療剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE132039T1 true ATE132039T1 (de) | 1996-01-15 |
Family
ID=14190880
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT91105883T ATE132039T1 (de) | 1990-04-12 | 1991-04-12 | Verwendung von steroidderivaten zur behandlung der endometriose |
Country Status (5)
Country | Link |
---|---|
US (1) | US5166200A (de) |
EP (1) | EP0451869B1 (de) |
JP (1) | JP2602456B2 (de) |
AT (1) | ATE132039T1 (de) |
DE (1) | DE69115745T2 (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5567828A (en) * | 1995-06-07 | 1996-10-22 | Eli Lilly And Company | Compounds and compositions with nitrogen-containing non-basic side |
WO1999007381A1 (en) * | 1997-08-11 | 1999-02-18 | Weider Nutrition International, Inc. | Compositions and treatments to reduce side effects of administration of androgenic testosterone precursors |
UA74168C2 (uk) * | 1999-10-05 | 2005-11-15 | Коламбіа Леборетеріс (Бермуда) Лімітед | Лікування ендометріозу або безпліддя, або покращення плідності та застосування бета-адренергічного агоніста для виробництва лікарського засобу |
GB0120147D0 (en) * | 2001-08-17 | 2001-10-10 | Metris Therapeutics Ltd | Treatment method |
EP1450849A4 (de) * | 2001-11-06 | 2005-06-29 | Applied Research Systems | Verfahren zur behandlung von endometreose |
GB0302572D0 (en) | 2003-02-05 | 2003-03-12 | Astrazeneca Ab | Method of treatment |
US20050101579A1 (en) * | 2003-11-06 | 2005-05-12 | Shippen Eugene R. | Endometriosis treatment protocol |
US20100087402A1 (en) * | 2008-09-29 | 2010-04-08 | Vivus, Inc. | Methods and compositions for the treatment of estrogen-dependent hyperproliferative uterine disorders |
DE102010003494A1 (de) * | 2010-03-31 | 2011-10-06 | Bayer Schering Pharma Aktiengesellschaft | Parenterales Abgabesystem, das Aromatasehemmer und Gestagene freisetzt, für die Behandlung von Endometriose |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8605405D0 (en) * | 1986-03-05 | 1986-04-09 | Erba Farmitalia | 3-deoxo-10beta-alkynyl steroids |
US4749713A (en) * | 1986-03-07 | 1988-06-07 | Ciba-Geigy Corporation | Alpha-heterocycle substituted tolunitriles |
GB8617107D0 (en) * | 1986-07-14 | 1986-08-20 | Erba Farmitalia | 6-/7-methylenandrosta-1 4-diene-3 17-dione derivatives |
GB8624251D0 (en) * | 1986-10-09 | 1986-11-12 | Erba Farmitalia | "1,2-beta-methylene-4-substituted androstene-3,17 dione derivatives |
ATE78825T1 (de) * | 1987-02-06 | 1992-08-15 | Snow Brand Milk Products Co Ltd | Neue androst-4-en-3,17-dion-derivate und verfahren zur herstellung. |
JPS63192794A (ja) * | 1987-02-06 | 1988-08-10 | Snow Brand Milk Prod Co Ltd | 14α−ヒドロキシ−4−アンドロステン−3,6,17−トリオン |
GB8711579D0 (en) * | 1987-05-15 | 1987-06-17 | Erba Farmitalia | 4-amino-androstenedione derivatives |
JPH01131193A (ja) * | 1987-08-07 | 1989-05-24 | Snow Brand Milk Prod Co Ltd | 14α−ヒドロキシ−アンドロスト−4−エン−3,6,17−トリオンのエステル誘導体 |
-
1990
- 1990-04-12 JP JP2097379A patent/JP2602456B2/ja not_active Expired - Lifetime
-
1991
- 1991-04-11 US US07/683,647 patent/US5166200A/en not_active Expired - Fee Related
- 1991-04-12 EP EP91105883A patent/EP0451869B1/de not_active Expired - Lifetime
- 1991-04-12 AT AT91105883T patent/ATE132039T1/de not_active IP Right Cessation
- 1991-04-12 DE DE69115745T patent/DE69115745T2/de not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US5166200A (en) | 1992-11-24 |
DE69115745T2 (de) | 1996-05-15 |
DE69115745D1 (de) | 1996-02-08 |
JP2602456B2 (ja) | 1997-04-23 |
EP0451869A2 (de) | 1991-10-16 |
EP0451869B1 (de) | 1995-12-27 |
EP0451869A3 (en) | 1992-07-08 |
JPH03294230A (ja) | 1991-12-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE7903186L (sv) | Cerebralverksamt medel | |
NO154918C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin. | |
NO912630D0 (no) | Fremgangsmaate for fremstilling av nye 2,6-dialkyl-4-silyl-fenoler. | |
NO147987C (no) | 1,2,3-thiadiazol-5-carboxylsyrederivater med herbicid vekstregulerende virkning | |
ATE121295T1 (de) | Augentropfenarzneimittel. | |
TW248519B (de) | ||
ATE132039T1 (de) | Verwendung von steroidderivaten zur behandlung der endometriose | |
DE69834500D1 (de) | Xanthinderivative zur behandlung von hirnischämie | |
ATE81004T1 (de) | Laktamimide in der behandlung arzneiresistenter protozoeninjektionen. | |
NO155665C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 5,6,7,7a-tetrahydro-4h-thieno-(3,2-c)-pyridin-2-on-derivater. | |
ATE35812T1 (de) | Gamma-butyrolactonderivate, verfahren zur herstellung derselben und dieselben als aktive bestandteile enthaltende immunomodulierende zubereitungen. | |
DE3853804D1 (de) | Zearalanol-Derivate mit anabolytischer Wirkung. | |
ATE122681T1 (de) | 19-substituierte progesterone als 19-hydroxylase- inhibitoren. | |
HU910694D0 (en) | Process for stabilizing 3-isothiazoles by means of hexamethylenetetramine | |
IE46171L (en) | N-pyrrolidinylmethylbenzamide derivative. | |
NO164095C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive estere av 3-(3-substituerte-amino-2-hydroksypropoksy)-4-substituerte-1,2,5-tiadiazolderivater. | |
DE69023459D1 (de) | Behandlung von pulmonarer Disfunktion mit 15-Keto-prostaglandin-Derivaten. | |
MD1762B2 (ro) | Derivaţi de pirazoliloxipiridină, procedeu de obţinere a lor, compoziţie erbicidă, procedeu de combatere a plantelor indezirabile | |
TW366259B (en) | N-arylthiohydrazone derivatives as insecticidal and acaricidal agents | |
ZA91762B (en) | Use of benzylphosphonic acid derivatives for the treatment of diseases caused by viruses | |
NO172491C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksan-alkensyre-dervater | |
IT1162680B (it) | N-(1-metil 2-pirrolidinilmetil) 2,3 dimetossi-5-metilsolfamoil benzammi de e suoi derivati utili per il trattamento dei disturbi dell'apparato urinario e procedimento di preparazione | |
ATE146964T1 (de) | Behandlung von katarakt mit prostacyclinverbindungen | |
MY109202A (en) | Isothiazole derivatives and processes for preparing the same as well as termite controlling agents comprising the same as active ingredient | |
MY131655A (en) | Amide derivatives,their production processes and their compositions for the control of insect pests |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |